// App-Quantinova.ai

1060 : Targeting serine hydroxymethyltransferase 2 (SHMT2) suppresses hepatocarcinoma

Researchers

Presenter

  • Chern Chiuh Woo

Principal Investigators

  • Way Cherng Chen

  • Teck Hock Philip Lee

Medical Centers

  • Singapore Bioimaging Consortium, Singapore, Singapore.

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • Phosphoglycerate Dehydrogenase

  • Phosphoserine Aminotransferase 1

  • Glycine Decarboxylase

Drug/Treatment

  • Tetracycline

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved